Skip to main content

Viatris news and events in 2026

We have combined with Upjohn, a legacy division of Pfizer, and are now Viatris. Follow along on our new journey as we empower people worldwide to live healthier at every stage of life.

Public (VTRS)Pharmaceutical Manufacturing10,000+ employeesviatris.comLinkedIn

Dated updates
73
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
84
Latest SEC filing
Aug 6, 2026

Overview

Viatris by topic

Latest events

Latest Viatris events

  1. Recognition
  2. New customer
  3. Launch
    Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea...Viatris announced that its drug WAKIX® (pitolisant) has received approval from Japan's Ministry of Health, Labour and Welfare for treating excessive daytime sleepiness associated with obstructive sleep apnea syndrome and for narcolepsy.
  4. Earnings
    Viatris Lifts 2026 Outlook After Strong Second QuarterViatris reported an adjusted EBITDA of $1.2 billion for the second quarter of 2026, up 8% operationally.
  5. In development
    VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape OutlookViatris anticipates the potential launch of its fast-acting meloxicam product.
  6. Earnings
    Viatris Announces Quarterly DividendViatris Inc. declared a quarterly dividend of $0.12 per share.
  7. Launch
    Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive PatchViatris received U.S. FDA approval for Gwyn Lo, a new once-weekly combined hormonal contraceptive patch with low-dose estrogen.
  8. Revenue
    Viatris Reports Second-Quarter 2026 Financial ResultsViatris reported total revenues of $3.757 billion for the second quarter of 2026, a 5% increase from the $3.582 billion reported in the same period of 2025.
  9. Award
  10. Executive hire
    Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs OfficerLara Ramsburg, Chief People and Corporate Affairs Officer

Showing 10 of 16 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Viatris with the Signal API

One POST /v1/companies/enrich call with viatris.com returns every signal type for Viatris, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"viatris.com","limit":20}'

Same industry

Viatris questions

What is the latest news on Viatris?
On Sep 29, 2026, prnewswire.com reported: Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year. This page tracks 16 news events for Viatris since Oct 8, 2025, each with a date and a source link.
What is going on with Viatris?
In the 90 days to Sep 30, 2026, Autobound tracked 7 news events, 1 10-Q filing, 4 hiring snapshots, 36 signals for Viatris. The newest story is from Sep 29, 2026 (Recognition), reported by prnewswire.com.
What else does Autobound track for Viatris?
Beyond news and filings, Autobound lists 48+ signals for Viatris from 5 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), Patents (2), Web traffic (1). See the Viatris signals page for the dated list.
Is Viatris hiring right now?
Yes. As of Sep 29, 2026, Viatris had 84 open roles, and Legal had the most with 14.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →